October 26, 2016 09:32 AM EDT
News Briefing

GV backs new ge­nomics R&D up­start; Ver­tex ad­vances plans for next-gen CF drugs

Shehla Shakoor

Managing Director

GV — for­mer­ly known as Google Ven­tures — is join­ing a syn­di­cate pro­vid­ing a $40 mil­lion Se­ries A round to Dublin-based Ge­nomics Med­i­cine Ire­land. The com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times